Cargando…

MEF2C Silencing Attenuates Load-Induced Left Ventricular Hypertrophy by Modulating mTOR/S6K Pathway in Mice

BACKGROUND: The activation of the members of the myocyte enhancer factor-2 family (MEF2A, B, C and D) of transcription factors promotes cardiac hypertrophy and failure. However, the role of its individual components in the pathogenesis of cardiac hypertrophy remains unclear. METHODOLOGY/PRINCIPAL FI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, Ana Helena M., Clemente, Carolina F. M. Z., Cardoso, Alisson C., Theizen, Thais H., Rocco, Silvana A., Judice, Carla C., Guido, Maria Carolina, Pascoal, Vinícius D. B., Lopes-Cendes, Iscia, Souza, José Roberto M., Franchini, Kleber G.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794538/ https://www.ncbi.nlm.nih.gov/pubmed/20041152 http://dx.doi.org/10.1371/journal.pone.0008472

Ejemplares similares

Correction: MEF2C Silencing Attenuates Load-Induced Left Ventricular Hypertrophy by Modulating mTOR/S6K Pathway in Mice
Publicado: (2014)

Immediate response of myocardium to pressure overload includes transient regulation of genes associated with mitochondrial bioenergetics and calcium availability
por: Deckmann, Ana Carolina, et al.
Publicado: (2010)

Central Exercise Action Increases the AMPK and mTOR Response to Leptin
por: Ropelle, Eduardo R., et al.
Publicado: (2008)

mTOR/PRAS40 interaction: Hypertrophy or proliferation
por: Völkers, Mirko, et al.
Publicado: (2013)

Analysis of energetically biased transcripts of viruses and transposable elements
por: Secolin, Rodrigo, et al.
Publicado: (2012)

ZO-2 silencing induces renal hypertrophy through a cell cycle mechanism and the activation of YAP and the mTOR pathway
por: Domínguez-Calderón, Alaide, et al.
Publicado: (2016)

Phosphatidic acid enhances mTOR signaling and resistance exercise induced hypertrophy
por: Joy, Jordan M, et al.
Publicado: (2014)

TFEC contributes to cardiac hypertrophy by inhibiting AMPK/mTOR signaling
por: Zhao, Ting, et al.
Publicado: (2021)

Targeting mTOR in Acute Lymphoblastic Leukemia
por: Simioni, Carolina, et al.
Publicado: (2019)

mTOR inhibitor improves testosterone-induced myocardial hypertrophy in hypertensive rats
por: Chen, Jianshu, et al.
Publicado: (2021)

Cortical neuronal hypertrophy and mTOR pathway activation in CAN regions in SUDEP
por: Patodia, Smriti, et al.
Publicado: (2022)

A review of ancestrality and admixture in Latin America and the caribbean focusing on native American and African descendant populations
por: De Oliveira, Thais C., et al.
Publicado: (2023)

MEF2C repressor variant deregulation leads to cell cycle re-entry and development of heart failure
por: Pereira, Ana Helena M., et al.
Publicado: (2020)

Androgen interacts with exercise through the mTOR pathway to induce skeletal muscle hypertrophy
por: Zeng, Fanxing, et al.
Publicado: (2017)

KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy
por: Wang, Yi, et al.
Publicado: (2021)

Effects of lactate administration on hypertrophy and mTOR signaling activation in mouse skeletal muscle
por: Shirai, Takanaga, et al.
Publicado: (2022)

Hyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia
por: Tong, Wing-Hang, et al.
Publicado: (2022)

Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin
por: Winbanks, Catherine E., et al.
Publicado: (2012)

The new world of RNAs
por: Dogini, Danyella Barbosa, et al.
Publicado: (2014)

The Programming of Cardiac Hypertrophy in the Offspring by Maternal Obesity Is Associated with Hyperinsulinemia, AKT, ERK, and mTOR Activation
por: Fernandez-Twinn, Denise S., et al.
Publicado: (2012)

mTOR inhibition impairs extinction memory reconsolidation
por: Radiske, Andressa, et al.
Publicado: (2021)

The Akt-mTOR axis is a pivotal regulator of eccentric hypertrophy during volume overload
por: Ikeda, Masataka, et al.
Publicado: (2015)

AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo
por: Cha, Byung-Hyun, et al.
Publicado: (2021)

Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway
por: Yeh, Tzu-Shao, et al.
Publicado: (2014)

miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation
por: Li, Z, et al.
Publicado: (2017)

Tripartite motif 27 promotes cardiac hypertrophy via PTEN/Akt/mTOR signal pathways
por: Chen, Yan, et al.
Publicado: (2022)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Hypoxia Activates the PTHrP –MEF2C Pathway to Attenuate Hypertrophy in Mesenchymal Stem Cell Derived Cartilage
por: Browe, David C., et al.
Publicado: (2019)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016)

The orphan receptor TR3 participates in angiotensin II-induced cardiac hypertrophy by controlling mTOR signalling
por: Wang, Rong-Hao, et al.
Publicado: (2013)

ATP-Induced Increase in Intracellular Calcium Levels and Subsequent Activation of mTOR as Regulators of Skeletal Muscle Hypertrophy
por: Ito, Naoki, et al.
Publicado: (2018)

p38γ and δ promote heart hypertrophy by targeting the mTOR-inhibitory protein DEPTOR for degradation
por: González-Terán, Bárbara, et al.
Publicado: (2016)

Alpha-ketoglutarate promotes skeletal muscle hypertrophy and protein synthesis through Akt/mTOR signaling pathways
por: Cai, Xingcai, et al.
Publicado: (2016)

Medical applications of RNA interference (RNAi)
por: Pereira, Tiago Campos, et al.
Publicado: (2013)

Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy
por: Wang, Changbing, et al.
Publicado: (2020)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

β-Hydroxy-β-methylbutyrate (HMβ) supplementation stimulates skeletal muscle hypertrophy in rats via the mTOR pathway
por: Pimentel, Gustavo D, et al.
Publicado: (2011)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Longitudinal MRI Volumetric Evaluation in Patients with Familial Mesial Temporal Lobe Epilepsy
por: Conz, Livia, et al.
Publicado: (2011)

Silencing of Twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibition
por: Jin, H-O, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5hl7haj0s3vmg53080pf81q3oa